These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 22902022)
1. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience. Groen LA; Hoebeke P; Loret N; Van Praet C; Van Laecke E; Ann R; Vande Walle J; Everaert K J Urol; 2012 Oct; 188(4):1313-7. PubMed ID: 22902022 [TBL] [Abstract][Full Text] [Related]
2. Preliminary results of sacral neuromodulation in 23 children. Humphreys MR; Vandersteen DR; Slezak JM; Hollatz P; Smith CA; Smith JE; Reinberg YE J Urol; 2006 Nov; 176(5):2227-31. PubMed ID: 17070300 [TBL] [Abstract][Full Text] [Related]
3. The dysfunctional elimination syndrome in children--is sacral neuromodulation worth the trouble? Dwyer ME; Reinberg YE J Urol; 2012 Oct; 188(4):1076-7. PubMed ID: 22901582 [No Abstract] [Full Text] [Related]
4. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children. Roth TJ; Vandersteen DR; Hollatz P; Inman BA; Reinberg YE J Urol; 2008 Jul; 180(1):306-11; discussion 311. PubMed ID: 18499169 [TBL] [Abstract][Full Text] [Related]
5. Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents. Sharifiaghdas F World J Urol; 2019 Dec; 37(12):2775-2783. PubMed ID: 30864008 [TBL] [Abstract][Full Text] [Related]
6. A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data. Spinelli M; Malaguti S; Giardiello G; Lazzeri M; Tarantola J; Van Den Hombergh U Neurourol Urodyn; 2005; 24(4):305-9. PubMed ID: 15977260 [TBL] [Abstract][Full Text] [Related]
7. Sacral Nerve Stimulation for Pediatric Lower Urinary Tract Dysfunction: Development of a Standardized Pathway with Objective Urodynamic Outcomes. Schober MS; Sulkowski JP; Lu PL; Minneci PC; Deans KJ; Teich S; Alpert SA J Urol; 2015 Dec; 194(6):1721-6. PubMed ID: 26141849 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project. Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W Urologia; 2012; 79(2):90-6. PubMed ID: 22610844 [TBL] [Abstract][Full Text] [Related]
12. Sacral nerve stimulator revision due to somatic growth. Clark C; Ngo T; Comiter CV; Anderson R; Kennedy W J Urol; 2011 Oct; 186(4 Suppl):1576-80. PubMed ID: 21855923 [TBL] [Abstract][Full Text] [Related]
13. Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study. Bosch JL; Groen J J Urol; 2000 Apr; 163(4):1219-22. PubMed ID: 10737501 [TBL] [Abstract][Full Text] [Related]
14. Long-term results of sacral neuromodulation with the tined lead procedure. Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820 [TBL] [Abstract][Full Text] [Related]
15. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy. Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028 [TBL] [Abstract][Full Text] [Related]
16. Sacral nerve stimulation for refractory overactive bladder in the elderly population. White WM; Mobley JD; Doggweiler R; Dobmeyer-Dittrich C; Klein FA J Urol; 2009 Oct; 182(4):1449-52. PubMed ID: 19683295 [TBL] [Abstract][Full Text] [Related]
17. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. Spinelli M; Giardiello G; Gerber M; Arduini A; van den Hombergh U; Malaguti S J Urol; 2003 Nov; 170(5):1905-7. PubMed ID: 14532804 [TBL] [Abstract][Full Text] [Related]
18. Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation? Peters KM; Killinger KA; Boura JA Neurourol Urodyn; 2011 Nov; 30(8):1489-92. PubMed ID: 21674596 [TBL] [Abstract][Full Text] [Related]
19. Sacral neuromodulation for refractory detrusor overactivity in women with an artificial urinary sphincter. Roupret M; Chartier-Kastler E; Almeras C; Ayoub N; Haertig A; Richard F J Urol; 2004 Jul; 172(1):236-9. PubMed ID: 15201782 [TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. Peeters K; Sahai A; De Ridder D; Van Der Aa F BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]